These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 3180084

  • 1. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.
    Marsman DS, Cattley RC, Conway JG, Popp JA.
    Cancer Res; 1988 Dec 01; 48(23):6739-44. PubMed ID: 3180084
    [Abstract] [Full Text] [Related]

  • 2. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643.
    Conway JG, Tomaszewski KE, Olson MJ, Cattley RC, Marsman DS, Popp JA.
    Carcinogenesis; 1989 Mar 01; 10(3):513-9. PubMed ID: 2924396
    [Abstract] [Full Text] [Related]

  • 3. Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid.
    Marsman DS, Goldsworthy TL, Popp JA.
    Carcinogenesis; 1992 Jun 01; 13(6):1011-7. PubMed ID: 1600604
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 01; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suppression of choline-deficient diet-induced hepatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio(N-beta-hydroxyethyl)- acetamide and di(2-ethylhexyl)phthalate.
    Perera MI, Katyal SL, Shinozuka H.
    Cancer Res; 1986 Jul 01; 46(7):3304-8. PubMed ID: 3708564
    [Abstract] [Full Text] [Related]

  • 10. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
    Doull J, Cattley R, Elcombe C, Lake BG, Swenberg J, Wilkinson C, Williams G, van Gemert M.
    Regul Toxicol Pharmacol; 1999 Jun 01; 29(3):327-57. PubMed ID: 10388618
    [Abstract] [Full Text] [Related]

  • 11. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-344 rats fed di(2-ethylhexyl)phthalate for 2 years.
    Cattley RC, Conway JG, Popp JA.
    Cancer Lett; 1987 Dec 01; 38(1-2):15-22. PubMed ID: 3690505
    [Abstract] [Full Text] [Related]

  • 12. NMR spectroscopic analyses of liver phosphatidylcholine and phosphatidylethanolamine biosynthesis in rats exposed to peroxisome proliferators-A class of nongenotoxic hepatocarcinogens.
    Reo NV, Adinehzadeh M.
    Toxicol Appl Pharmacol; 2000 Apr 15; 164(2):113-26. PubMed ID: 10764624
    [Abstract] [Full Text] [Related]

  • 13. Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators.
    Takagi A, Sai K, Umemura T, Hasegawa R, Kurokawa Y.
    J Environ Pathol Toxicol Oncol; 1992 Apr 15; 11(3):145-9. PubMed ID: 1625184
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific changes in the protein composition of rat liver in response to the peroxisome proliferators ciprofibrate, Wy-14,643 and di-(2-ethylhexyl)phthalate.
    Watanabe T, Lalwani ND, Reddy JK.
    Biochem J; 1985 May 01; 227(3):767-75. PubMed ID: 4004798
    [Abstract] [Full Text] [Related]

  • 16. [Correlation of the ability of Di(2-ethylhexyl)phthalate to induce cell transformation, chromosome aberrations, and peroxisome proliferation in cultured Syrian hamster embryo cells].
    Watanabe E, Tsutsui T.
    Shigaku; 1989 Dec 01; 77(4):1371-90. PubMed ID: 2489351
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ability of peroxisome proliferators to induce cell transformation, chromosome aberrations and peroxisome proliferation in cultured Syrian hamster embryo cells.
    Tsutsui T, Watanabe E, Barrett JC.
    Carcinogenesis; 1993 Apr 01; 14(4):611-8. PubMed ID: 8472324
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643.
    Obourn JD, Frame SR, Bell RH, Longnecker DS, Elliott GS, Cook JC.
    Toxicol Appl Pharmacol; 1997 Aug 01; 145(2):425-36. PubMed ID: 9266817
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of various peroxisome proliferators on peroxisomal enzyme activities, DNA synthesis, and apoptosis in rat and human hepatocyte cultures.
    Goll V, Alexandre E, Viollon-Abadie C, Nicod L, Jaeck D, Richert L.
    Toxicol Appl Pharmacol; 1999 Oct 01; 160(1):21-32. PubMed ID: 10502499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.